Innovation Pharmaceuticals Inc (IPIX)

[eddiebali]

The second Pfizer multikinase inhibitors name ?
Sunitinib (Sutent) we know, anybody have a clue about the second ??????



"Additional studies are being conducted at Beth Israel Deaconess to research Kevetrin in conjunction with [b]two Pfizer multikinase inhibitors as potential new therapies for renal cancer and melanoma."


Axitinib
(Inlyta®) Description
Pfizer Oral multikinase inhibitor that targets VEGFR-1, -2, -3.
Approved indications:
Advanced renal cell carcinoma after failure of one prior systemic therapy.

http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=65&abstractID=31517
Phase I dose escalation trial of tremelimumab plus sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC).

http://www.thepharmaletter.com/file/20144/pfizer-revives-development-of-tremelimumab-for-advanced-melanoma-in-deal-with-debiopharm.html